Armata Pharmaceuticals, Inc. Logo

Armata Pharmaceuticals, Inc. (ARMP)

NYSE

Currency in USD
3.86
+0.05 (+1.31%)

Closed

Oct 8, 2026

Day's Range

3.60
3.91

52 wk Range

3.09
16.34

Profile - ARMP - Armata Pharmaceuticals, Inc.

Profile

Mic Code

XASE

Sector

Healthcare

Industry

Biotechnology

Employees

61


Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections. The company’s current work centers on phage-based medicines designed to target specific bacterial pathogens, with programs addressing infections such as Staphylococcus aureus bacteremia and Pseudomonas aeruginosa-related disease. Its platform combines natural and synthetic bacteriophages with proprietary engineering, microbiological surveillance, and drug development capabilities to support product design, manufacturing, and clinical testing. Armata Pharmaceuticals operates as a specialist in infectious disease therapeutics, serving an important role in the broader biopharmaceutical market by advancing alternative approaches to conventional antibiotics.

Profile Details

Type

Common Stock

Address

5005 McConnell Avenue

City

Los Angeles

State

CA

Zip

90066

Country

United States

Phone

310 665 2928

Key Executives - ARMP - Armata Pharmaceuticals, Inc.

Key executives

NamePositionAgePay
Dr. Deborah L. Birx M.D.CEO & Director68851.90K
Mr. Peter HubbardVice President of Operations--
Ms. Bani Tchekanova Ph.D.Head of Regulatory Strategy & Operations--
Dr. Pierre Kyme Ph.D.Chief Business Officer47625.75K

Cross Listings - ARMP - Armata Pharmaceuticals, Inc.

Also listed on

The same company trading on other exchanges.

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.